ClinicalTrials.gg
Status unknownNCT05792215Updated Aug 2, 2024

KAP of Dental Practitioners Regarding CRA

An observational study in Caries,Dental, Tooth Decay and Tooth Diseases, sponsored by Cairo University. Status unknown. Per ClinicalTrials.gov, last updated 2024-08-02.

Sponsored by Cairo University · Observational

The sponsor has not verified this record recently (last verified Aug 2024), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
174
Sex
All
01

Study summary

The aim of the study is to evaluate the knowledge, attitude, and practice of a group of dental practitioners from Cairo and Riyadh regarding caries risk assessment and management.

Read the detailed description

Dental caries is a preventable major public health disease affecting people of all ages and substantially impacting overall health. Caries remain the single most common chronic childhood disease. Dental caries is a dynamic and complex process. Several variables influence the occurrence of dental caries, including oral flora, saliva flow and composition, and lifestyle. Dental caries development can be primary (new carious lesion) or secondary (lesion progression or reactivated carious lesions).

There has been much progress over the past several decades in the prevention of dental caries, shifting from the management of dental caries from a "surgical approach" to a "medical prevention strategy", based on a better understanding of the caries disease process.

Caries Risk Assessment (CRA) is a significant part of successfully applying the minimum intervention dentistry philosophy in managing dental caries. As recommended by AAPD, Dental caries-risk assessment should be a routine component of new and periodic examinations by oral health and medical providers. Therefore, this study aims to assess the knowledge, attitude, and practice of a group of dental practitioners from Cairo and Riyadh regarding caries risk assessment and management.

Benefits to Practitioner:

  • Increasing awareness of the importance of CRA practices.
  • Implementing a positive attitude regarding CRA and management.
  • Improve practices toward CRA

Benefits to Patient:

  • Increasing the awareness and knowledge of early caries prevention by dentists.
  • Increasing awareness about Caries Risk Assessment and management.

Benefits to Community:

  • Increasing the knowledge and awareness of the community regarding preventive dentistry and the importance of primary prevention
02

Conditions studied

  • Caries,Dental
  • Tooth Decay
  • Tooth Diseases

Keywords

  • Caries Risk Assessment
  • Caries Prevention
  • General Practitioners
03

In context

Dental Caries

1,137 studies on the registry are indexed under Dental Caries; 201 are open to participants now.

This study's planned enrollment of 174 is close to the median of 178 across 185 observational studies indexed under Dental Caries.

Browse Dental Caries studies →

Lead sponsor

Cairo University is the lead sponsor of 4,907 studies on the registry; 1,445 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

All licensed Egyptian and Saudi general dentists

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Licensed Egyptian and Saudi general dentists.

Exclusion criteria

Exclusion Criteria:

  • Undergraduate dental students
  • Dental specialists
  • Dentists who refused to participate
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
174 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Knowledge, Attitude, and Practice of Dental Practitioners in Cairo and Riyadah

    Questionnaire The questionnaire is composed of the following sections: (A) Sociodemographic data including participants' age, gender, qualification, experience years, place of practice, and the number of pediatric patients they see every week. (B) Participants' knowledge of caries risk assessment indicators. Section (B) will contain binary questions (true and false) (C) Participants' attitudes and knowledge related to caries risk assessment and management. section (C) will contain three-point Likert scale (''Agree'', ''Disagree'' and "Neither agree nor disagree") (D) Barriers in caries risk assessment and management practices. Section (D) will contain a four-point Likert-type scale (always, often, sometimes, and never.)

    Time frame: 1 year

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 2, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05792215
Lead sponsor
Cairo University
Responsible party
Waleed Saqer Saeed Almutairi (Principal Investigator, Cairo University) — Principal investigator
First posted
Mar 31, 2023
Start date
Sep 1, 2024 (estimated)
Primary completion
Oct 1, 2024 (estimated)
Completion
Oct 30, 2024 (estimated)
Last update
Aug 2, 2024

Study contacts

Waleed S Almutairi, Masters
Contact
waleed.saqer@dentistry.cu.edu.eg
0551568955
Gihan M Abuelniel, Professor
study chair · Professor

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion